Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 589

1.

Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA).

Burmester GR, Rubbert-Roth A, Cantagrel A, Hall S, Leszczynski P, Feldman D, Rangaraj MJ, Roane G, Ludivico C, Bao M, Rowell L, Davies C, Mysler EF.

Ann Rheum Dis. 2015 Jun 8. pii: annrheumdis-2015-207281. doi: 10.1136/annrheumdis-2015-207281. [Epub ahead of print]

2.

Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force.

Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, Kvien TK, Navarro-Compán MV, Oliver S, Schoels M, Scholte-Voshaar M, Stamm T, Stoffer M, Takeuchi T, Aletaha D, Andreu JL, Aringer M, Bergman M, Betteridge N, Bijlsma H, Burkhardt H, Cardiel M, Combe B, Durez P, Fonseca JE, Gibofsky A, Gomez-Reino JJ, Graninger W, Hannonen P, Haraoui B, Kouloumas M, Landewe R, Martin-Mola E, Nash P, Ostergaard M, Östör A, Richards P, Sokka-Isler T, Thorne C, Tzioufas AG, van Vollenhoven R, de Wit M, van der Heijde D.

Ann Rheum Dis. 2015 May 12. pii: annrheumdis-2015-207524. doi: 10.1136/annrheumdis-2015-207524. [Epub ahead of print]

3.

Near-infrared Fluorescence Optical Imaging in Early Rheumatoid Arthritis: A Comparison to Magnetic Resonance Imaging and Ultrasonography.

Krohn M, Ohrndorf S, Werner SG, Schicke B, Burmester GR, Hamm B, Backhaus M, Hermann KA.

J Rheumatol. 2015 Jul;42(7):1112-1118. Epub 2015 May 1.

PMID:
25934821
4.

The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkers.

Kopetschke K, Klocke J, Grießbach AS, Humrich JY, Biesen R, Dragun D, Burmester GR, Enghard P, Riemekasten G.

Arthritis Res Ther. 2015 Apr 3;17(1):94. [Epub ahead of print]

5.

The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus.

Alexander T, Sarfert R, Klotsche J, Kühl AA, Rubbert-Roth A, Lorenz HM, Rech J, Hoyer BF, Cheng Q, Waka A, Taddeo A, Wiesener M, Schett G, Burmester GR, Radbruch A, Hiepe F, Voll RE.

Ann Rheum Dis. 2015 Jul;74(7):1474-8. doi: 10.1136/annrheumdis-2014-206016. Epub 2015 Feb 20.

6.

Increased frequency of JC-polyomavirus detection in rheumatoid arthritis patients treated with multiple biologics.

Verheyen J, Maizus K, Feist E, Tolman Z, Knops E, Saech J, Spengler L, Waterboer T, Burmester GR, Pawlita M, Pfister H, Rubbert-Roth A.

Med Microbiol Immunol. 2015 Feb 13. [Epub ahead of print]

PMID:
25678083
7.

Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE.

Humrich JY, von Spee-Mayer C, Siegert E, Alexander T, Hiepe F, Radbruch A, Burmester GR, Riemekasten G.

Ann Rheum Dis. 2015 Apr;74(4):791-2. doi: 10.1136/annrheumdis-2014-206506. Epub 2015 Jan 21. No abstract available.

PMID:
25609413
8.

Circadian rhythms of cellular immunity in rheumatoid arthritis: a hypothesis-generating study.

Spies CM, Hoff P, Mazuch J, Gaber T, Maier B, Strehl C, Hahne M, Jakstadt M, Huscher D, Burmester GR, Detert J, Kramer A, Buttgereit F.

Clin Exp Rheumatol. 2015 Jan-Feb;33(1):34-43. Epub 2014 Dec 22.

PMID:
25535886
9.

The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal Diseases.

Al Maini M, Adelowo F, Al Saleh J, Al Weshahi Y, Burmester GR, Cutolo M, Flood J, March L, McDonald-Blumer H, Pile K, Pineda C, Thorne C, Kvien TK.

Clin Rheumatol. 2015 May;34(5):819-29. doi: 10.1007/s10067-014-2841-6. Epub 2014 Dec 14.

10.

Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation.

Sieber J, Daridon C, Fleischer SJ, Fleischer V, Hiepe F, Alexander T, Heine G, Burmester GR, Fillatreau S, Dörner T.

Arthritis Res Ther. 2014 Nov 11;16(6):477. doi: 10.1186/s13075-014-0477-1.

11.

Effects of 60-day bed rest with and without exercise on cellular and humoral immunological parameters.

Hoff P, Belavý DL, Huscher D, Lang A, Hahne M, Kuhlmey AK, Maschmeyer P, Armbrecht G, Fitzner R, Perschel FH, Gaber T, Burmester GR, Straub RH, Felsenberg D, Buttgereit F.

Cell Mol Immunol. 2014 Nov 10. doi: 10.1038/cmi.2014.106. [Epub ahead of print]

PMID:
25382740
12.

Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period.

Emery P, Burmester GR, Bykerk VP, Combe BG, Furst DE, Barré E, Karyekar CS, Wong DA, Huizinga TW.

Ann Rheum Dis. 2015 Jan;74(1):19-26. doi: 10.1136/annrheumdis-2014-206106. Epub 2014 Nov 3.

13.

Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trial.

Detert J, Klaus P, Listing J, Höhne-Zimmer V, Braun T, Wassenberg S, Rau R, Buttgereit F, Burmester GR.

Trials. 2014 Oct 27;15:412. doi: 10.1186/1745-6215-15-412.

14.

[Rheumatoid factor or antinuclear antibodies as incidental finding].

Biesen R, Burmester GR, Hiepe F.

Internist (Berl). 2014 Oct;55(10):1157-64. doi: 10.1007/s00108-014-3588-5. German.

PMID:
25269385
15.

Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients.

Derganova O, Martinez-Gamboa L, Egerer K, Bang H, Fredenhagen G, Roggenbuck D, Esaulenko I, Burmester GR, Chernykh T, Feist E.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5):622-9. Epub 2014 Sep 5.

PMID:
25189876
16.

Tofacitinib with methotrexate in third-line treatment of patients with active rheumatoid arthritis: patient-reported outcomes from a phase III trial.

Strand V, Burmester GR, Zerbini CA, Mebus CA, Zwillich SH, Gruben D, Wallenstein GV.

Arthritis Care Res (Hoboken). 2015 Apr;67(4):475-83. doi: 10.1002/acr.22453.

PMID:
25186034
17.

Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.

Becker MO, Kill A, Kutsche M, Guenther J, Rose A, Tabeling C, Witzenrath M, Kühl AA, Heidecke H, Ghofrani HA, Tiede H, Schermuly RT, Nickel N, Hoeper MM, Lukitsch I, Gollasch M, Kuebler WM, Bock S, Burmester GR, Dragun D, Riemekasten G.

Am J Respir Crit Care Med. 2014 Oct 1;190(7):808-17. doi: 10.1164/rccm.201403-0442OC.

PMID:
25181620
18.

Upregulation of immunoproteasome subunits in myositis indicates active inflammation with involvement of antigen presenting cells, CD8 T-cells and IFNΓ.

Ghannam K, Martinez-Gamboa L, Spengler L, Krause S, Smiljanovic B, Bonin M, Bhattarai S, Grützkau A, Burmester GR, Häupl T, Feist E.

PLoS One. 2014 Aug 6;9(8):e104048. doi: 10.1371/journal.pone.0104048. eCollection 2014.

19.

[Interface between university medicine and patient care].

Jacobsen C, Burmester GR, Detert J.

Z Rheumatol. 2014 Aug;73(6):520-5. doi: 10.1007/s00393-014-1376-1. German.

PMID:
25037478
20.

Response to H Zeidler's comments on the CONCERTO study.

Burmester GR, Kivitz A, Kupper H, Arulmani U, Florentinus S, Goss SL, Rathmann SS, Fleischmann RM.

Ann Rheum Dis. 2014 Aug;73(8):e51. doi: 10.1136/annrheumdis-2014-205704. Epub 2014 Jun 9. No abstract available.

PMID:
24914070
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk